Back
Veris Residential Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
55
VRE
Veris Residential
Last Price:
$16.29
Seasonality Move:
11.48%
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
$74.08
Seasonality Move:
14.66%
Buy
55
Veris Residential (VRE)
is a Buy
Is Veris Residential a Buy, Sell or Hold?
-
The current Veris Residential [VRE] share price is $16.31. The Score for VRE is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
VRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRE Stock Price Chart
What is Veris Residential's stock price today?
-
The Veris Residential share price today is $16.31The current trend is relatively stagnant and VRE is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $74.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
VRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 50.69 | Buy |
Chaikin Money Flow: | 357215 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.85 - 16.63) | Buy |
Bollinger Bands (100): | (15.86 - 17.62) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.7 | Sell |
Relative Strength Index (14 RSI): | 27.9 | Sell |
Chaikin Money Flow: | -367389 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.59 - 111.17) | Sell |
Bollinger Bands (100): | (103.29 - 127.87) | Sell |
VRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.24 | Buy |
20-day SMA: | 16.35 | Sell |
50-day SMA: | 16.07 | Buy |
200-day SMA: | 16.52 | Sell |
8-day EMA: | 16.31 | Sell |
20-day EMA: | 16.29 | Buy |
50-day EMA: | 16.33 | Sell |
200-day EMA: | 16.41 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.22 | Sell |
20-day SMA: | 97.87 | Sell |
50-day SMA: | 108.64 | Sell |
200-day SMA: | 125.16 | Sell |
8-day EMA: | 84.58 | Sell |
20-day EMA: | 94.74 | Sell |
50-day EMA: | 105.16 | Sell |
200-day EMA: | 118.38 | Sell |
Veris Residential Earnings Growth & VRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
Veris Residential Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |